Register for a discovery session
Led by an Elanco veterinary technical expert, our live discovery sessions are an information-packed 45 minutes showcasing our latest feline innovations: Varenzin and Eluracat.
Varenzin™ is an oral suspension for the treatment of CKD anaemia in cats designed to be given at home by owners. Eluracat™ is also an oral suspension, designed to support cats with chronic medical conditions experiencing weight loss or poor appetite, gain and maintain weight over time.
Join one of our discovery sessions to find out more!
To listen to a discovery session, you’ll need to register first. It will only take a couple of minutes. Then you’re all set to learn more about Varenzin and Eluracat.
You'll receive information on how to prescribe Varenzin and Eluracat, including:
Current disease information and perspectives
How Varenzin and Eluracat work
Information on dosing, safety profile and pricing
Opportunity for Q&A
Additional Information
Eluracat
The only weight gain treatment for cats that activates their own physiological hunger pathways12
Varenzin 25 mg/ml Oral Suspension for Cats contains molidustat sodium. Legal category POM-V in GB.
Varenzin 23.3 mg/ml Oral Suspension for Cats contains molidustat sodium. Legal category POM in IE, POM-V in NI.
Eluracat 20 mg/ml oral solution for cats contains capromorelin 15.4 mg equivalent to 20 mg capromorelin tartrate. Legal category POM-V in UK, POM in IE.
Further information can be found in the Summary of Product Characteristics. Use medicines responsibly: www.noah.co.uk/responsible www.apha.ie . Advice should be sought from the prescriber prior to use. Prescription decisions are for the person issuing the prescription alone.
Eluracat™, Varenzin™, Elanco™ and the diagonal bar logo are trademarks of Elanco or its affiliates.
